Innospec INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
INNOSPEC Director Milton C. Blackmore filed an amended Form 4 to correct reported sale prices for common stock transactions on February 27, 2026.
NASDAQ
Innospec Director Larry Padfield filed an amended Form 4 to correct reported sale prices for common stock transactions on February 27, 2026.
NASDAQ
Innospec Inc. Director Claudia Poccia filed an amended Form 4 to correct the reported transaction prices for two sales of common stock on February 27, 2026.
NASDAQ
Innospec Director David Landless filed an amended Form 4 to correct previously reported stock sale prices from February 27, 2026.
NASDAQ
INNOSPEC's EVP & CFO, Ian Cleminson, filed an amended Form 4 to correct previously reported stock sale prices from February 27, 2026.
NASDAQ
Innospec Inc. Director Milton C. Blackmore reported the sale of 594 shares of common stock at $76.5562 per share.
NASDAQ
Innospec Director Larry Padfield reported a planned sale of 594 shares of common stock on February 27, 2026, at $76.5562 per share under a Rule 10b5-1 plan.
NASDAQ
INNOSPEC INC. Director Claudia Poccia sold 119 shares of common stock at $76.5562 per share to cover tax withholding obligations related to restricted stock unit vesting.
NASDAQ
Innospec's SVP of Human Resources, Hardy Louis Griffin III, sold 401 shares of common stock to cover tax liabilities from a restricted stock unit award vesting.
NASDAQ
INNOSPEC Director David Landless sold 594 shares of common stock at $76.5562 per share on February 27, 2026, under a Rule 10b5-1 plan.
NASDAQ
Innospec's SVP, General Counsel, and Chief Compliance Officer, David B. Jones, reported the sale of company common stock following the vesting of restricted stock units.
NASDAQ
Innospec Inc.'s SVP of Corporate Development and IR, Corbin Barnes, disposed of 166 shares of common stock to cover tax liabilities from a restricted stock unit vesting.
NASDAQ
Innospec Inc.'s EVP & CFO, Ian Cleminson, sold 2,380 shares of common stock for $76.56 per share under a pre-arranged plan.
NASDAQ
Innospec Inc.'s President and CEO, Patrick Williams, disposed of 7,966 shares of common stock to cover tax liabilities related to a restricted stock unit award vesting.
NASDAQ
Innospec Inc. SVP Corbin Barnes received a grant of 2,481 Restricted Stock Units, vesting in 2029.
NASDAQ
Innospec Inc.'s SVP of Human Resources, Hardy Louis Griffin III, was granted 2,521 Restricted Stock Units vesting in 2029.
NASDAQ
Innospec Inc.'s EVP & CFO, Ian Cleminson, was granted 4,499 Restricted Stock Units, vesting in full on February 23, 2029.
NASDAQ
Innospec Inc.'s President and CEO, Patrick Williams, was granted 20,846 Restricted Stock Units (RSUs) that will vest in 2029.
NASDAQ
INNOSPEC INC. Senior Vice President, General Counsel & Chief Compliance Officer David B. Jones was granted 2,993 Restricted Stock Units.
NASDAQ
Innospec Inc.'s Head of Group Finance, Graeme Blair, was awarded 520 phantom stock units, set to settle in cash in 2029.
NASDAQ
Innospec's Senior VP of R&T, Ian Malcolm McRobbie, was awarded 2,228 shares of phantom stock, set to settle in cash in 2029.
NASDAQ
INNOSPEC Director Elizabeth K. Arnold was granted 1,539 Restricted Stock Units as compensation for her service.
NASDAQ
Innospec Inc. Director Leslie J. Parrette was granted 1,539 Restricted Stock Units, vesting in 2029, as compensation for her non-employee director service.
NASDAQ
INNOSPEC Inc. Director David Landless was granted 1,539 Restricted Stock Units, vesting in 2029, as part of his non-employee director compensation.
NASDAQ
INNOSPEC Director Claudia Poccia was granted 1,539 Restricted Stock Units, vesting in 2029, increasing her beneficial ownership to 6,627 shares.
NASDAQ
Innospec Inc. Director Milton C. Blackmore reported exercising stock options, selling shares, and receiving new Restricted Stock Units.
NASDAQ
Innospec Director Larry Padfield reported the exercise of stock options, subsequent sale of shares, and the grant of restricted stock units.
NASDAQ
Innospec Inc. Director Leslie J. Parrette reported a planned acquisition of 340 shares of common stock at $74.09 per share, effective November 14, 2025, under a Rule 10b5-1 plan.
NASDAQ
Director Leslie J. Parrette sold shares of Innospec Inc. to cover tax withholding obligations related to vesting restricted stock units.
NASDAQ
Hardy Louis Griffin III, SVP of Human Resources at Innospec Inc., reports a transaction involving common stock related to the vesting of a restricted stock unit award.